The US flavors and fragrances market size is expected to reach USD 8.43 billion by 2034, according to a new study by Polaris Market Research. The report “US Flavors and Fragrances Market Size, Share, Trends, Industry Analysis Report: By Product (Natural and Aroma Chemicals) and By Application – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The market encompasses the formulation, production, and application of compounds that enhance the sensory attributes of consumables and personal care products. This market plays a pivotal role in product differentiation and consumer brand engagement across sectors, including food and beverages, cosmetics, pharmaceuticals, and home care. A notable driver of market growth is the escalating demand for clean-label and wellness-focused formulations, where botanical extracts, fermentation-derived ingredients, and essential oils are replacing synthetic counterparts. Heightened consumer awareness and regulatory pressure around ingredient transparency are compelling manufacturers to invest in natural, traceable, and sustainably sourced raw materials. Advancements in biotechnology, precision fermentation, and green chemistry are also supporting the development of novel compounds, expanding both technical capabilities and product portfolios.
Trends such as sensory branding, mood-enhancing aromas, and multisensory consumption are reinforcing US flavors and fragrances market demand, particularly in premium and niche applications. The increasing convergence of wellness and luxury in personal care and food categories is opening new opportunities for customized scent and flavor experiences. Moreover, innovation in encapsulation, controlled release, and AI-enabled flavor modeling is enabling manufacturers to deliver more consistent, high-performance outcomes. Strategic investments in R&D, formulation platforms, and sustainable sourcing strategies are fueling market expansion, as companies respond to evolving consumer preferences and competitive differentiation imperatives. The market is becoming more innovation-centric, value-driven, and responsive to shifts in lifestyle and consumption patterns, positioning it for resilient long-term growth.
US Flavors and Fragrances Market Report Highlights
Based on product, the US flavors and fragrances market is segmented into natural and aroma chemicals. The natural segment accounted for a larger market share in 2024 due to the surge in demand for botanical and organic inputs across food, beverage, and personal care applications.
In terms of application, the market is segmented into flavors and fragrances. The flavors segment held a larger market share in 2024 due to the ongoing expansion of the processed food and functional beverage sectors.
Alpha Aromatics; Archer-Daniels-Midland Company; BASF SE; dōTERRA International; Elevance Renewable Sciences, Inc.; International Flavors & Fragrances Inc.; Ungerer & Company; Vigon International, Inc.; and Young Living Essential Oils are a few key market players.
Polaris Market Research has segmented the market report on the basis of product and application:
By Product Outlook (Revenue, USD Billion, 2020–2034)
Natural
Essential Oils
Oleoresins
Others
Aroma Chemicals
By Application Outlook (Revenue, USD Billion, 2020–2034)
Flavors
Fragrances
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Device Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. US Cardiovascular Device Market Insights
- 4.1. US Cardiovascular Device Market – Market Snapshot
- 4.2. US Cardiovascular Device Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Aging Population and Increased Surgical Interventions
- 4.2.1.2. Increasing Awareness and Preventive Screenings
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of the Devices
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. US Cardiovascular Device Market Trends
- 4.6. Value Chain Analysis
- 5. US Cardiovascular Device Market, by Device Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. US Cardiovascular Device Market, by Device Type, 2020-2034 (USD billion)
- 5.3. Diagnostic And Monitoring Devices
- 5.3.1. US Cardiovascular Device Market, by Diagnostic and Monitoring Devices, 2020-2034 (USD billion)
- 5.3.2. Electrocardiogram
- 5.3.2.1. US Cardiovascular Device Market, by Electrocardiogram, 2020-2034 (USD billion)
- 5.3.3. Remote Cardiac Monitoring
- 5.3.3.1. US Cardiovascular Device Market, by Remote Cardiac Monitoring, 2020-2034 (USD billion)
- 5.3.4. MRI
- 5.3.4.1. US Cardiovascular Device Market, by MRI, 2020-2034 (USD billion)
- 5.3.5. Others
- 5.3.5.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
- 5.4. Therapeutic And Surgical Devices
- 5.4.1.1. US Cardiovascular Device Market, by Therapeutic and Surgical Devices, 2020-2034 (USD billion)
- 5.4.2. Ventricular Assist Devices
- 5.4.2.1. US Cardiovascular Device Market, by Ventricular Assist Devices, 2020-2034 (USD billion)
- 5.4.3. Cardiac Rhythm Management Devices
- 5.4.3.1. US Cardiovascular Device Market, by Cardiac Rhythm Management Devices, 2020-2034 (USD billion)
- 5.4.4. Catheter
- 5.4.4.1. US Cardiovascular Device Market, by Catheter, 2020-2034 (USD billion)
- 5.4.5. Stents
- 5.4.5.1. US Cardiovascular Device Market, by Stents, 2020-2034 (USD billion)
- 5.4.6. Others
- 5.4.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
- 6. US Cardiovascular Device Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. US Cardiovascular Device Market, by Application, 2020-2034 (USD billion)
- 6.3. Heart Failure
- 6.3.1. US Cardiovascular Device Market, by Heart Failure, 2020-2034 (USD billion)
- 6.4. Cardiac Arrhythmia
- 6.4.1. US Cardiovascular Device Market, by Cardiac Arrhythmia, 2020-2034 (USD billion)
- 6.5. Coronary Artery Disease
- 6.5.1. US Cardiovascular Device Market, by Steel Plate, 2020-2034 (USD billion)
- 6.6. Others
- 6.6.1. US Cardiovascular Device Market, by Others, 2020-2034 (USD billion)
- 7. US Cardiovascular Device Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. US Cardiovascular Device Market, by End Use, 2020-2034 (USD billion)
- 7.3. Hospitals
- 7.3.1. US Cardiovascular Device Market, by Hospitals, 2020-2034 (USD billion)
- 7.4. Ambulatory Surgical Centers
- 7.4.1. US Cardiovascular Device Market, by Ambulatory Surgical Centers, 2020-2034 (USD billion)
- 7.5. Specialty Clinics
- 7.5.1. US Cardiovascular Device Market, by Specialty Clinics, 2020-2034 (USD billion)
- 8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
- 9. Company Profiles
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. B. Braun Melsungen AG
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Biotronik SE & Co.KG
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. C. R. Bard, Inc.
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Cook Medicals
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Lepu Medicals
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Liaoning Biomedical Materials
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Medtronic Plc
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. Meril Life Sciences
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. MicroPort Scientific Corporation
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. Terumo Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. Translumina GmbH
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. Vascular Concepts
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. Jude Medical, Inc.
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. Edward lifesciences corporation
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook